STOCK TITAN

Dr. Marijn Dekkers Named Chairman of AgBiome Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary

AgBiome has appointed Dr. Marijn Dekkers as Chairman of the Board, effective January 1, 2021. Dekkers, a former CEO of Bayer AG and Thermo Fisher Scientific, will leverage his extensive experience to guide AgBiome's growth strategies. Notably, AgBiome is focused on developing natural crop protection products through its proprietary GENESIS™ discovery platform, targeting a significant market opportunity valued at 100 billion dollars. The company also collaborates with Elanco Animal Health to create nutritional health solutions for swine.

Positive
  • Dr. Dekkers' extensive leadership experience may enhance AgBiome's strategic direction.
  • Focus on sustainable farming aligns with market trends towards eco-friendly agricultural practices.
  • Strong investor backing and recent partnerships bolster AgBiome's growth potential.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., Jan. 19, 2021 /PRNewswire/ -- AgBiome, a leader in developing innovative products from the Earth's microbial communities, announced Dr. Marijn Dekkers as the company's Chairman, effective January 1, 2021.

Dr. Dekkers is the founder and chairman of Novalis LifeSciences, an investment and advisory firm for the Life Science industry. He formerly served as the CEO of Bayer AG, and before that, as CEO of Thermo Fisher Scientific Inc. Last year, Dr. Dekkers joined AgBiome as a strategic advisor -- lending his expertise, knowledge and business resources as AgBiome continued to execute on its growth phase objectives. Novalis joins AgBiome's elite group of investors that includes Polaris Partners, ARCH Venture Partners, Fidelity, UTIMCO, Pontifax AgTech, The Bill & Melinda Gates Foundation, Innotech Advisors, Syngenta Ventures, and Leaps by Bayer.

Eric Ward, co-CEO at AgBiome said, "With decades of exceptional leadership experience as a chief executive and in chairing boards of successful companies, alongside deep institutional knowledge across AgBiome's business and strategic prospects, Dr. Dekkers is the ideal next Chairman of the Board to lead AgBiome to the next chapter of success." Ward continued, "AgBiome is well positioned to execute on its strategic business model focused on our proprietary products, partner programs, joint ventures, and new company formations, all of which represent significant value opportunities for AgBiome in the near- and longer-term."

"I'm honored to have the opportunity to chair the AgBiome Board and work alongside Scott Uknes and Eric Ward, whose leadership and vision as co-CEOs have positioned the company to achieve extraordinary success over time," said Dr. Dekkers. "AgBiome's focus on developing naturally derived biological alternatives for traditional crop protection products is of high importance to the future of more sustainable farming and the environment. AgBiome's industry-leading microbial discovery platform plays a key role in accomplishing this mission," concluded Dr. Dekkers.

About AgBiome
AgBiome® partners with the microbial world to improve our planet. AgBiome discovers and develops innovative biological and trait products for crop protection. The proprietary GENESIS™ discovery platform efficiently captures diverse, unique microbes for agriculturally relevant applications, and screens them with industry-best assays for insect, disease, and nematode control. Through its commercial subsidiary, AgBiome develops and sells proprietary crop protection solutions, valued at a 100 billion dollar market opportunity. The first of these, Howler®, is a revolutionary fungicide for disease control in a broad variety of crops. AgBiome and Genective recently formed a strategic partnership to establish a new leader in insect traits. AgBiome has a global R&D collaboration with Elanco Animal Health Incorporated (NYSE: ELAN), to develop nutritional health products for swine. AgBiome's investors include Polaris Partners, ARCH Venture Partners, Fidelity Investments Inc., UTIMCO, Pontifax AgTech, Innotech Advisors, Syngenta Ventures, Leaps by Bayer, and Novozymes. For more information, visit http://agbiome.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/dr-marijn-dekkers-named-chairman-of-agbiome-board-of-directors-301210791.html

SOURCE AgBiome

FAQ

Who is the new Chairman of AgBiome?

Dr. Marijn Dekkers has been appointed as the new Chairman of AgBiome as of January 1, 2021.

What is Dr. Marijn Dekkers' background?

Dr. Dekkers is the former CEO of Bayer AG and Thermo Fisher Scientific and is currently also the chairman of Novalis LifeSciences.

What is AgBiome's market focus?

AgBiome focuses on developing biological crop protection products and has a market opportunity valued at 100 billion dollars.

What partnerships does AgBiome have?

AgBiome has a global R&D collaboration with Elanco Animal Health to develop nutritional health products for swine.

Elanco Animal Health Incorporated

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Stock Data

5.87B
490.44M
0.71%
98.94%
3.07%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GREENFIELD